Human antibodies specifically binding to the hepatitis B virus surface antigen
US8840895B2 · kind B2 · utility
1Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2010 |
| Grant date | Sep 23, 2014 |
| Priority date | — |
| Expiry date | Jul 8, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are antibodies specifically binding to the HBV surface antigen (HBsAg) which are effective for the prevention or treatment of hepatitis B.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.